Skip to main content
Clinical Trials/IRCT20230704058663N1
IRCT20230704058663N1
Not yet recruiting
未知

Investigating the effect of active exercise during dialysis on uremia and hyperphosphatemia in hemodialysis patient

Esfahan University of Medical Sciences0 sites66 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
66
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All dialysis patients who are over 18 years old.
  • All dialysis patients who have a fixed number of sessions per week and undergo hemodialysis 3 times a week and each session lasts for 4 hours.
  • All dialysis patients who have undergone hemodialysis for more than 3 months.
  • All dialysis patients who use a permanent vascular access.
  • All dialysis patients who are able to perform active range of motion exercises and pedal independently.
  • All dialysis patients who have the ability to learn exercises and do not have mental disabilities.
  • All dialysis patients who had stable hemodynamics during hemodialysis sessions in the last 1 month.

Exclusion Criteria

  • Patients with symptomatic and severe aortic stenosis
  • Patients who have a history of lung disease that requires oxygen therapy
  • Patients who do not have a history of stroke or transient ischemic attacks in the last 3\-6 months
  • Patients who have a history of heart attack and unstable angina in the past 3\-6 months.
  • Patients with a history of ischemic heart disease
  • Patients who have any disorders in the musculoskeletal system (orthopedic problems, lower limb amputations, etc.) that prevent them from performing the desired sports activities
  • Patients with uncontrolled blood pressure.
  • Patients with uncontrolled diabetes.
  • Patients who have a history of moderate to severe heart failure (class \=II according to New York Heart Association criteria).
  • Patients with a history of angina pectoris grade 2\-4 according to the criteria of the Canadian Heart and Vascular Association

Outcomes

Primary Outcomes

Not specified

Similar Trials